Study details
Enrolling now
Intra-articular Platelet-Rich Plasma vs. Viscosupplementation for Knee Osteoarthritis
Endeavor Health
NCT IDNCT03491761ClinicalTrials.gov data as of Apr 2026
Phase
Phase 2
Target enrollment
100
Study length
about 9.6 years
Ages
18–75
Locations
1 site in IL
About this study
Researchers are testing whether platelet-rich plasma (PRP) is more effective than hyaluronic acid (HA) in treating knee osteoarthritis. The trial will measure changes in cartilage thickness and pain/function using the KOOS questionnaire to compare PRP and HA treatments.
Based on ClinicalTrials.gov records.
What participants do
- 1.Receive HA Treatment
- 2.Receive PRP Treatment
PhasePhase 2
Primary goalCartilage Thickness on MRI
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low12%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Endpoints
Primary: Cartilage Thickness on MRI
Body systems
Musculoskeletal